Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Mercator MedSystems board of directors update

    Mercator MedSystems Inc., San Leandro, Calif. Business: Drug delivery Appointed: Joel Kanter, president of Windy City Inc.; Ned Scheetz, founder of Aphelion Capital; and Doug Wall, partner at Volcano Capital

    Published on 6/10/2013
  • Mirna management update

    Mirna Therapeutics Inc., Austin, Texas Business: Cancer Hired: Sinil Kim as VP of oncology and CMO, formerly senior director at Pfizer Inc.

    Published on 6/10/2013
  • Oxford BioMedica management update

    Oxford BioMedica plc (LSE:OXB), Oxford, U.K. Business: Cancer, Gene/Cell therapy, Neurology Departing: Stuart Naylor as CSO and a director Hired: Madhu Davies, an Oxford BioMedica consultant, as CMO, a newly created …

    Published on 6/10/2013
  • Protagonist Therapeutics board of directors update

    Protagonist Therapeutics Inc., Redwood City, Calif. Business: Infectious, Cancer Appointed: Asish Xavier, vice president of venture investments at Johnson & Johnson Development Corp.

    Published on 6/10/2013
  • Protagonist Therapeutics management update

    Protagonist Therapeutics Inc., Redwood City, Calif. Business: Infectious, Cancer Hired: David Liu as CSO, formerly COO of Trenovus Inc.

    Published on 6/10/2013
  • PTC management update

    PTC Therapeutics Inc., South Plainfield, N.J. Business: Pulmonary, Cancer, Infectious Hired: Shane Kovacs as CFO, formerly managing director of health care investment banking at Credit Suisse

    Published on 6/10/2013
  • Sinovac management update

    Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Transitioned: VP Nan Wang to CFO; she succeeds Danny Chung, who resigned

    Published on 6/10/2013
  • Spectrum Pharmaceuticals management update

    Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI), Henderson, Nev. Business: Cancer Hired: Kurt Gustafson as EVP, principal accounting officer, and CFO, formerly VP and CFO at Halozyme Therapeutics Inc. Transitioned: Brett …

    Published on 6/10/2013
  • SQI Diagnostics board of directors update

    SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Appointed: Claude Ricks as chairman; he replaces Eric Schneider, who remains a director

    Published on 6/10/2013
  • SQI Diagnostics management update

    SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Promoted: Andrew Morris to president and CEO from CFO, effective June 17; he replaces Claude Ricks, who was promoted to chairman

    Published on 6/10/2013
  • T2 Biosystems management update

    T2 Biosystems Inc., Lexington, Mass. Business: Diagnostic Hired: Marc Jones as CFO, formerly CFO of Crashlytics Inc., which Twitter Inc. acquired

    Published on 6/10/2013
  • Trius management update

    Trius Therapeutics Inc. (NASDAQ:TSRX), San Diego, Calif. Business: Infectious Hired: Matthew Onaitis as general counsel and secretary, a newly created position, formerly SVP, general counsel and secretary of Somaxon …

    Published on 6/10/2013
  • Verastem management update

    Verastem Inc. (NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Transitioning: COO Robert Forrester to CEO and a director while remaining president, effective July 1; he succeeds Chairman and CEO Christoph Westphal, who …

    Published on 6/10/2013
  • Ziopharm management update

    Ziopharm Oncology Inc. (NASDAQ:ZIOP), New York, N.Y. Business: Cancer Departed: Jason Amello as EVP, treasurer and CFO Transitioned: Kevin Lafond to VP of finance, treasurer, principal financial officer and chief …

    Published on 6/10/2013
  • Achillion management update

    Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Transitioned: President of R&D and CSO Milind Deshpande to president, CEO and a director; he succeeds Michael Kishbauch, who remains a …

    Published on 6/3/2013
  • Atopix Therapeutics board of directors update

    Atopix Therapeutics Ltd., London, U.K. Business: Dermatology Appointed: Mike Carter, venture partner at SV Life Sciences; Luke Evnin, managing director at MPM Capital; and Regina Hodits, general partner at Wellington …

    Published on 6/3/2013
  • BioInvent management update

    BioInvent International AB (SSE:BINV), Lund, Sweden Business: Cardiovascular, Cancer, Antibodies Hired: Michael Oredsson as president and CEO, effective within six months, formerly CEO of Probi AB

    Published on 6/3/2013
  • Daiichi Sankyo management update

    Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Business: Pharmaceuticals Promoted: Gideon Bollag to CEO of Daiichi's Plexxikon Inc. subsidiary from SVP of research; he replaces Peter Hirth, who retired; …

    Published on 6/3/2013
  • Kala Pharmaceuticals management update

    Kala Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic, Drug delivery Hired: Charles McDermott as EVP of business development, formerly VP of business development for eye care and drug delivery at Allergan Inc.

    Published on 6/3/2013
  • Ophthotech board of directors update

    Ophthotech Corp., New York, N.Y. Business: Ophthalmic Transitioned: Samir Patel to vice chairman while remaining president

    Published on 6/3/2013
  • Ophthotech management update

    Ophthotech Corp., New York, N.Y. Business: Ophthalmic Transitioned: Chairman David Guyer to CEO

    Published on 6/3/2013
  • Probi management update

    Probi AB (SSE:PROB), Lund, Sweden Business: Nutraceuticals Transitioning: VP of R&D Gun-Britt Fransson to interim CEO; she replaces Michael Oredsson, who is departing

    Published on 6/3/2013
  • Silence Therapeutics management update

    Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Promoted: Ali Mortazavi to CEO from director of corporate strategy; he is replaced by Annie Cheng, formerly a strategy consultant for …

    Published on 6/3/2013
  • Simcere management update

    Simcere Pharmaceutical Group (NYSE:SCR), Nanjing, China Business: Cancer, Generics Resigned: Peng Wang as CSO, for personal reasons

    Published on 6/3/2013
  • Singulex management update

    Singulex Inc., Alameda, Calif. Business: Diagnostic, Supply/Service Transitioned: Guido Baechler to president, CEO and a director from SVP of operations; he succeeds Philippe Goix, who departed

    Published on 6/3/2013

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993